Literature DB >> 1676900

Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction.

H Naito1, N Kuzumaki, J Uchino, R Kobayashi, T Shikano, Y Ishikawa, S Matsumoto.   

Abstract

To facilitate the diagnosis of bone marrow metastasis in neuroblastoma, we have developed a method of amplifying and detecting the tyrosine hydroxylase (TH) mRNA sequence in bone marrow cells using a combination of reverse transcription and the polymerase chain reaction (RT/PCR). By this method, the sequence of TH was detected clearly in the neuroblastoma tissues of all 6 patients and not detected in the bone marrow cells of any of the 9 negative control children. In a reconstitution experiment, 1 neuroblastoma cell per 100,000 normal bone marrow cells could be detected, thus indicating the great sensitivity of this method. Based on these results, this technique may be of value in the diagnosis and treatment follow-up of bone marrow metastasis of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676900     DOI: 10.1016/0277-5379(91)90184-f

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

1.  Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.

Authors:  G G Wulf; B Jürgens; T Liersch; W Gatzemeier; H Rauschecker; C Buske; M Hüfner; W Hiddemann; B Wörmann
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies.

Authors:  J Gilbert; M Haber; S B Bordow; G M Marshall; M D Norris
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 3.  WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Authors:  Daniela Maria Rasà; Agata Grazia D'Amico; Grazia Maugeri; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2017-05-22       Impact factor: 3.444

Review 4.  Cellular kinetics of neuroblastoma and the role of surgery.

Authors:  Tatsuo Kuroda
Journal:  Pediatr Surg Int       Date:  2011-07-19       Impact factor: 1.827

5.  Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.

Authors:  Fabio Morandi; Sabrina Chiesa; Paola Bocca; Enrico Millo; Annalisa Salis; Massimo Solari; Vito Pistoia; Ignazia Prigione
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

6.  Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.

Authors:  Nai-Kong V Cheung; Irina Ostrovnaya; Deborah Kuk; Irene Y Cheung
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

Review 7.  Circulating tumor cells in breast cancer: methodology and clinical repercussions.

Authors:  J M Gasent Blesa; V Alberola Candel; E Esteban González; J Vidal Martínez; R Gisbert Criado; M Provencio Pulla; J Laforga Canales; K Pachmann
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

8.  Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.

Authors:  P H Sorensen; J K Wu; K W Berean; J F Lim; W Donn; H F Frierson; C P Reynolds; D López-Terrada; T J Triche
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

9.  Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells.

Authors:  D-C Mou; S-L Cai; J-R Peng; Y Wang; H-S Chen; X-W Pang; X-S Leng; W-F Chen
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR.

Authors:  Michael P Raynor; Sally-Anne Stephenson; Kenneth B Pittman; David C A Walsh; Michael A Henderson; Alexander Dobrovic
Journal:  J Hematol Oncol       Date:  2009-06-05       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.